Biodexa Pharmaceticals Ownership
| BDRX Stock | 4.38 0.45 11.45% |
Biodexa Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biodexa Pharmaceticals recorded a loss per share of 26.12. The entity last dividend was issued on the 3rd of March 2020. The firm had 1:10 split on the 31st of July 2025. For more info on Biodexa Pharmaceticals please contact Stephen Stamp at 44 29 2048 0180 or go to https://www.biodexapharma.com.Biodexa Pharmaceticals Outstanding Bonds
Biodexa Pharmaceticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biodexa Pharmaceticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biodexa bonds can be classified according to their maturity, which is the date when Biodexa Pharmaceticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.